CARIS LIFE SCIENCES, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
CARIS LIFE SCIENCES, INC. (CAI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $2.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.44M, a 3.03% decline year-over-year.
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.32M, a 8.88% decline year-over-year.
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.26M, a 8.35% decline year-over-year.
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.39M, a 3.82% increase year-over-year.
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $5.58M, a 0.29% decline from fiscal 2024.
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $5.60M, a 29.29% increase from fiscal 2023.
- CARIS LIFE SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $4.33M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.76M 10-Q · filed 2026-08-05 | $4.02M derived: sum of 3 quarters · filed 2026-08-05 | $5.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.32M 10-Q · filed 2026-05-08 | $2.58M derived: sum of 2 quarters · filed 2026-05-08 | $3.97M derived: sum of 3 quarters · filed 2026-05-08 | $5.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.65M derived: sum of 2 quarters · filed 2026-03-03 | $4.13M derived: sum of 3 quarters · filed 2026-08-05 | $5.58M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.87M derived: sum of 2 quarters · filed 2026-08-05 | $4.32M 10-Q · filed 2025-11-05 | $5.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.94M 10-Q · filed 2026-08-05 | $4.31M derived: sum of 3 quarters · filed 2026-08-05 | $5.65M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.45M 10-Q · filed 2026-05-08 | $2.83M derived: sum of 2 quarters · filed 2026-05-08 | $4.17M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.71M derived: sum of 2 quarters · filed 2026-03-03 | $5.60M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.22M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $2.89M 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $4.33M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |